RSS   Newsletter   Contact   Advertise with us
Post Online Media

Voyager Therapeutics appoints Jane Pritchett Henderson as CFO

Voyager TherapeuticsVoyager Therapeutics, a clinical-stage gene therapy company, announced the appointment of Jane Pritchett Henderson as senior vice president and chief financial officer.

Ms. Henderson brings more than 28 years of life sciences industry and banking experience and leadership to her new role.

READ MORE Voyager Therapeutics promotes Jeff Goater to CFO

Ms. Henderson most recently served as chief financial and business officer of Kolltan Pharmaceuticals, Inc., having joined the privately-held biopharmaceutical company in 2013 and leading the sale of Kolltan to Celldex Pharmaceuticals, Inc., in late 2016.

Previously, Ms. Henderson served as vice president, business development of ISTA Pharmaceuticals, Inc., from June 2010 to June 2012, when ISTA Pharmaceuticals was acquired by Bausch + Lomb.

Prior to ISTA Pharmaceuticals, Ms. Henderson also served as the chief financial officer and head of business development at Axerion Pharmaceuticals, Inc., and as chief financial officer and chief business officer of Panacos Pharmaceuticals, Inc.

She currently serves on the Board of Directors of Eleven Biotherapeutics, Inc.

Ms. Henderson received a B.S. in Psychology from Duke University.




What to read next



 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy